Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia?-Reference-Cited by-同舟云学术

Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia?

Published:2018-03-11 Issue:6 Volume:20 Page:1337-1341
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Khunti Kamlesh¹^ORCID,Kosiborod Mikhail²,Ray Kausik K.³

Affiliation:

1. Leicester Diabetes Centre; University of Leicester; Leicester UK

2. Department of Cardiology; Saint Luke's Mid America Heart Institute and University of Missouri; Kansas City Missouri

3. Department of Primary Care and Public Health, Centre for Cardiovascular Disease Prevention; Imperial College London; London UK

Funder

National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC - EM)

NIHR Leicester, Biomedical Research Centre

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13243/fullpdf

Reference30 articles.

1. Cardiovascular disease and risk management;American Diabetes Association;Diabetes Care,2015

2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus;The Diabetes Control and Complications Trial Research Group;N Engl J Med,1993

3. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes;The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group;N Engl J Med,2005

4. 10-Year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

5. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes;Zoungas;N Engl J Med,2014

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin Resistance in Long COVID-19 Syndrome;Journal of Personalized Medicine;2024-08-28

2. Treatment intensification and therapeutic inertia of antihypertensive therapy among patients with type 2 diabetes and hypertension with uncontrolled blood pressure;Scientific Reports;2024-06-01

3. Indirect effects of the COVID-19 pandemic on diagnosing, monitoring, and prescribing in people with diabetes and strategies for diabetes service recovery internationally;Diabetes Research and Clinical Practice;2024-06

5. Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta‐analysis of trials investigating intensive glucose‐lowering strategies in people with type 2 diabetes;Diabetes, Obesity and Metabolism;2024-02-26